Mapping the locus of autosomal dominant polycystic kidney disease: Diagnostic application

S. T. Reeders, G. G. Germino, G. A J Gillespie

Research output: Contribution to journalArticle

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common autosomal dominant disorders affecting humans. The recent identification of a number of restriction fragment length polymorphisms linked to ADPKD now offers a method for diagnosis in families that are large enough for linkage and phase of linkage to be established. Initial studies of >50 families with the disease localized all disease-producing mutations to the short arm of chromosome 16. Recently, however, families have been identified in which linkage to 16p markers cannot be detected. Such genetic heterogeneity of linkage limits the value of diagnostic methods based on linkage analysis and focuses attention on the need for direct diagnosis of disease-producing mutations. This in turn requires the isolation, cloning, and characterization of ADPKD genes. A refined map of the region around the PKD1 gene, the ADPKD gene localized on chromosome 16p, is presented.

Original languageEnglish (US)
JournalClinical Chemistry
Volume35
Issue number7 SUPPL.
StatePublished - 1989
Externally publishedYes

Fingerprint

Autosomal Dominant Polycystic Kidney
Genes
Chromosomes, Human, Pair 16
Mutation
Genetic Linkage
Chromosomes
Genetic Heterogeneity
Restriction Fragment Length Polymorphisms
Organism Cloning
Cloning
Polymorphism

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Reeders, S. T., Germino, G. G., & Gillespie, G. A. J. (1989). Mapping the locus of autosomal dominant polycystic kidney disease: Diagnostic application. Clinical Chemistry, 35(7 SUPPL.).

Mapping the locus of autosomal dominant polycystic kidney disease : Diagnostic application. / Reeders, S. T.; Germino, G. G.; Gillespie, G. A J.

In: Clinical Chemistry, Vol. 35, No. 7 SUPPL., 1989.

Research output: Contribution to journalArticle

Reeders, ST, Germino, GG & Gillespie, GAJ 1989, 'Mapping the locus of autosomal dominant polycystic kidney disease: Diagnostic application', Clinical Chemistry, vol. 35, no. 7 SUPPL..
Reeders, S. T. ; Germino, G. G. ; Gillespie, G. A J. / Mapping the locus of autosomal dominant polycystic kidney disease : Diagnostic application. In: Clinical Chemistry. 1989 ; Vol. 35, No. 7 SUPPL.
@article{f4b6cdac75c948d8ad57610ebf7b1144,
title = "Mapping the locus of autosomal dominant polycystic kidney disease: Diagnostic application",
abstract = "Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common autosomal dominant disorders affecting humans. The recent identification of a number of restriction fragment length polymorphisms linked to ADPKD now offers a method for diagnosis in families that are large enough for linkage and phase of linkage to be established. Initial studies of >50 families with the disease localized all disease-producing mutations to the short arm of chromosome 16. Recently, however, families have been identified in which linkage to 16p markers cannot be detected. Such genetic heterogeneity of linkage limits the value of diagnostic methods based on linkage analysis and focuses attention on the need for direct diagnosis of disease-producing mutations. This in turn requires the isolation, cloning, and characterization of ADPKD genes. A refined map of the region around the PKD1 gene, the ADPKD gene localized on chromosome 16p, is presented.",
author = "Reeders, {S. T.} and Germino, {G. G.} and Gillespie, {G. A J}",
year = "1989",
language = "English (US)",
volume = "35",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "7 SUPPL.",

}

TY - JOUR

T1 - Mapping the locus of autosomal dominant polycystic kidney disease

T2 - Diagnostic application

AU - Reeders, S. T.

AU - Germino, G. G.

AU - Gillespie, G. A J

PY - 1989

Y1 - 1989

N2 - Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common autosomal dominant disorders affecting humans. The recent identification of a number of restriction fragment length polymorphisms linked to ADPKD now offers a method for diagnosis in families that are large enough for linkage and phase of linkage to be established. Initial studies of >50 families with the disease localized all disease-producing mutations to the short arm of chromosome 16. Recently, however, families have been identified in which linkage to 16p markers cannot be detected. Such genetic heterogeneity of linkage limits the value of diagnostic methods based on linkage analysis and focuses attention on the need for direct diagnosis of disease-producing mutations. This in turn requires the isolation, cloning, and characterization of ADPKD genes. A refined map of the region around the PKD1 gene, the ADPKD gene localized on chromosome 16p, is presented.

AB - Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common autosomal dominant disorders affecting humans. The recent identification of a number of restriction fragment length polymorphisms linked to ADPKD now offers a method for diagnosis in families that are large enough for linkage and phase of linkage to be established. Initial studies of >50 families with the disease localized all disease-producing mutations to the short arm of chromosome 16. Recently, however, families have been identified in which linkage to 16p markers cannot be detected. Such genetic heterogeneity of linkage limits the value of diagnostic methods based on linkage analysis and focuses attention on the need for direct diagnosis of disease-producing mutations. This in turn requires the isolation, cloning, and characterization of ADPKD genes. A refined map of the region around the PKD1 gene, the ADPKD gene localized on chromosome 16p, is presented.

UR - http://www.scopus.com/inward/record.url?scp=0024309003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024309003&partnerID=8YFLogxK

M3 - Article

C2 - 2568192

AN - SCOPUS:0024309003

VL - 35

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 7 SUPPL.

ER -